Skip to main content
    A

    Aurinia Pharmaceuticals Inc (AUPH)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $15.40
    -0.08 (-0.52%)

    Market Cap: $2.11B

    Last updated: Nov 17, 2026 at 4:24 PM ET

    Aurinia Pharmaceuticals Inc (AUPH) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Aurinia Pharmaceuticals (AUPH) has a latest price of $15.40 on Nov 17, 2026, 20.0% below its 52-week high of $19.25. Its price rose 0.3% over the past 12 months. The month-end price rose 449.5% over the 10 years through Oct 2026, a compound annual rate of 18.6%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $33.08 in Oct 2021 and its lowest $2.10 in Dec 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart AUPH with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for AUPH.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 4.8%, and over 6 months it fell 1.0%. The month-end price rose 126.8% over the 3 years through Oct 2026, a compound annual rate of 31.4%.

    PeriodChange
    1 month-6.6%
    3 months-4.8%
    6 months-1.0%
    12 months+0.3%
    12 months, with dividends+0.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+126.8%+31.4%
    5 years-49.7%-12.8%
    10 years+449.5%+18.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 197.1%, and its weakest was 2022, when it fell 81.1%.

    YearCloseChange
    2026 through Oct 2026$16.65+4.4%
    2025$15.95+77.6%
    2024$8.98-0.1%
    2023$8.99+108.1%
    2022$4.32-81.1%
    2021$22.87+65.4%
    2020$13.83-31.7%
    2019$20.26+197.1%
    2018$6.82+50.6%
    2017$4.53+115.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 6.4% below its 50-day average of $16.46 and 2.1% below its 200-day average of $15.74.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$15.40
    52-week high$19.25-20.0%
    52-week low$13.52+13.9%
    50-day average$16.46-6.4%
    200-day average$15.74-2.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 49.3%.

    MeasureValue
    1-year beta0.67
    Largest fall, 1 year-21.8%
    Largest fall, 3 years-49.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About AUPH

    What is AUPH's 1-year price change?

    Aurinia Pharmaceuticals's price rose 0.3% over the past 12 months. With dividends included, the 12-month total return was 0.3%.

    What is AUPH's 5-year price change?

    Aurinia Pharmaceuticals's month-end price fell 49.7% over the 5 years through Oct 2026, a compound annual decline of 12.8%. These figures leave out dividends.

    What is AUPH's 52-week high and low?

    Aurinia Pharmaceuticals's 52-week high is $19.25 and its 52-week low is $13.52. Its latest price of $15.40 on Nov 17, 2026 is 20.0% below the high.

    What is AUPH's beta?

    Aurinia Pharmaceuticals's 1-year beta against the S&P 500 is 0.67, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 21.8%.

    Is the AUPH chart free?

    Yes. Advanced Charting for AUPH is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.